SKIN Earnings & Financial Statements
The Beauty Health Company
$0.59
+$0.00(+0.67%)
45
Overall
60
Value
30
Tech
47
Quality
Market Cap
$76.77M
Volume
219.42K
52W Range
$0.55 - $2.03
Target Price
$1.05
SKIN earnings and financial statements: The Beauty Health Company's income statement, balance sheet and cash flow statement, annual and quarterly.
SKIN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $300.79M | $334.29M | $397.99M | $365.88M | $260.09M |
| Cost of revenue | $104.43M | $152.00M | $242.88M | $117.10M | $81.55M |
| Operating income | -$20.80M | -$67.77M | -$130.92M | -$25.84M | -$36.64M |
| EBITDA | $42.37M | $17.86M | -$49.34M | $85.83M | -$351.08M |
| Net income | -$9.52M | -$29.10M | -$100.12M | $44.22M | -$378.76M |
| EPS (diluted) | $-0.16 | $-0.36 | $-0.76 | $-0.23 | $-3.67 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $499.80M | $685.68M | $929.11M | $1.00B | $1.22B |
| Total liabilities | $438.75M | $633.88M | $869.72M | $836.03M | $916.51M |
| Shareholders’ equity | $61.06M | $51.80M | $59.39M | $167.05M | $302.30M |
| Cash and equivalents | - | - | $523.02M | $568.20M | $901.89M |
| Long-term debt | $249.67M | $563.01M | $747.69M | $746.83M | $742.70M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $37.48M | $16.13M | $21.75M | -$106.60M | -$28.36M |
| Capital expenditure | -$5.16M | -$6.79M | -$13.05M | -$17.39M | -$15.62M |
| Free cash flow | $32.32M | $9.34M | $8.70M | -$123.99M | -$43.98M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SKIN | $0.59 | +0.7% | 219.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get The Beauty Health Company Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW